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Background: Scaffold proteins have an important role in the regulation of signal propagation. These proteins do
not possess any enzymatic activity but can contribute to the formation of multiprotein complexes. Although
scaffold proteins are present in all cell types, the nervous system contains them in the largest amount. Caskin
proteins are typically present in neuronal cells, particularly, in the synapses. However, the signaling mechanisms by
which Caskin proteins are regulated are largely unknown.
Results: Here we demonstrate that EphB1 receptor tyrosine kinase can recruit Caskin1 through the adaptor protein
Nck. Upon activation of the receptor kinase, the SH2 domain of Nck binds to one of its tyrosine residues, while Nck
SH3 domains interact with the proline-rich domain of Caskin1. Complex formation of the receptor, adaptor and
scaffold proteins results in the tyrosine phosphorylation of Caskin1 on its SH3 domain. The phosphorylation sites
were identified by mass-spectrometry as tyrosines 296 and 336. To reveal the structural consequence of this
phosphorylation, CD spectroscopy was performed. This measurement suggests that upon tyrosine phosphorylation
the structure of the Caskin1 SH3 domain changes significantly.
Conclusion: Taken together, we propose that the scaffold protein Caskin1 can form a complex with the EphB1
tyrosine kinase via the Nck protein as a linker. Complex formation results in tyrosine phosphorylation of the Caskin1
SH3 domain. Although we were not able to identify any physiological partner of the SH3 domain so far, we could
demonstrate that phosphorylation on conserved tyrosine residues results in marked changes in the structure of the
SH3 domain.
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The Eph family is the largest family of receptor tyrosine
kinases, at least, 14 different Eph kinases have been
identified so far [1,2]. These receptors can be divided
into two subclasses (EphB and EphA) based on the cell
surface ligand which they interact with. Ligands that
interact with EphA receptors are generally attached to
the cell surface via glycosylphosphatidylinositol (ephrinA
ligands), while ligands that activate EphB receptors are* Correspondence: buday.laszlo@ttk.mta.hu
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reproduction in any medium, provided the ortransmembrane proteins (ephrinB ligands) [1,2]. Eph re-
ceptor kinases and their ligands (ephrins) play a critical
role in embryonic patterning, angiogenesis and neuronal
targeting [2-4]. In the nervous system, EphB receptor
kinases are enriched at excitatory synapses and are im-
portant during synapse and spine formation and main-
tenance [2].
Adaptor proteins, composed almost entirely of well-
defined interaction domains, serve to link two functional
members of a signaling pathway [5]. Nck family of adap-
tors comprising of SH2 and SH3 domains are implicated
in the organization of actin cytoskeleton, cell movement,
and axon guidance. Their SH2 domains bind specific
phosphotyrosine residues on activated receptors or theird. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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motifs on downstream target proteins [6]. It has been
shown earlier that Nck associates with a number of Eph
tyrosine kinases, including EphB1, EphB2, EphA2,
EphA3 and EphA4 [7-12]. For EphB1, the first tyrosine
residue localized in the juxtamembrane region represents
the binding site for the SH2 domain of Nck, while its SH3
domains may interact with paxillin, Nck-interacting kinase
(NIK), or WASP [7-9,13].
Neurons contain numerous scaffold proteins that are
involved in the regulation of synaptic function [14].
Cask-interactive proteins (Caskins) also belong to this
group of scaffold proteins [15]. Caskin1 and its isoform
Caskin2 are multidomain proteins possessing six ankyrin
repeats, a single SH3 domain, and two sterile α motifs
(SAM domains) in the N-terminal part [15]. In contrast,
there are no recognizable domains in the C-terminal
part, which is dominated by a long proline-rich region
[15]. Recently, we provided evidence that the entire
proline-rich region of Caskin1 is intrinsically disordered.
We also showed that the proline-rich region is biochem-
ically functional, as it interacts with the adaptor protein
Abl-interactor-2 (Abi2) [16]. In addition to CASK and
Abi2, Caskin1 can also interact with Nck/Dock, neur-
exin2, synaptotagmin, and septin4 [12,16,17]. A Caskin
homolog has been recently discovered in Drosophila
and shown to be involved in LAR receptor tyrosine
phosphatase-mediated motor axon guidance [17]. Recent
data suggest that the tandem SAM domains of Caskin1
form a novel SAM polymer containing eight SAM
domains per helical turn with an unusually long helical
pitch. This special feature of Caskin1 may also contribute
to the organization of synaptic function [18].
Here we show that receptor tyrosine kinase EphB1 can
form a complex with Caskin1 through the adaptor pro-
tein Nck. Upon activation of the receptor kinase, the
SH2 domain of Nck binds to one of its tyrosine residues,
while the Nck SH3 domains interact with the proline-
rich domain of Caskin1. Complex formation of the re-
ceptor kinase, adaptor, and scaffold proteins results in
the phosphorylation of tyrosine residues 296 and 336
localized in the SH3 domain of Caskin1. Using CD spec-
troscopy we found that upon tyrosine phosphorylation
the structure of the Caskin1 SH3 domain changes
significantly.
Results
Nck interacts with Caskin1 in an SH3 domain-dependent
manner
We and others have shown earlier that the scaffold pro-
tein Caskin1 interacts with Nck/Dock [8,12,16,17]. To
confirm and characterize the interaction between the
two proteins, first, endogenous Caskin1 was immuno-
precipitated (IP) from rat brain lysate with a monoclonalanti-Caskin1 antibody. After SDS-PAGE and transfer to
nitrocellulose, samples were analyzed by anti-Nck and
anti-Caskin1 antibodies. As Figure 1a shows Caskin1
interacts stably with Nck in vivo. To study the inter-
action in another system, V5 epitope-tagged Caskin1
and/or GFP-tagged Nck were transiently expressed in
COS7 cells, and then cell lysates were immunoprecipi-
tated with an anti-V5 antibody. When both proteins
were coexpressed in cells, Caskin1 was capable of associ-
ating with Nck (Figure 1b). Nck possesses an SH2 and
three SH3 domains [6]. Although it has been shown
earlier that the interaction between Caskin1 and Nck is
mediated through SH3 domains [12], it has not been
determined which SH3 domain(s) is responsible for the
association. Therefore, to determine the required SH3
domains for the Caskin1/Nck interaction, full length
Nck, the three SH3 domains together (Nck-SH3-all), and
individual SH3 domains (SH3/1, SH3/2 and SH3/3) were
generated as GST fusion proteins. These fusion proteins
were immobilized on glutathione-agarose beads and
used for protein precipitations from lysates of COS7
cells expressing V5-Caskin1. As seen in Figure 1c, none
of the individual SH3 domains of Nck was able to pull-
down the scaffold protein. However, when all three SH3
domains were combined, either in the full length Nck or
the Nck-SH3-all construct, Caskin1 was readily precipi-
tated. These findings suggest that similar to many of the
Nck-interacting proteins (described in the Discussion)
Caskin1 requires all SH3 domains of Nck for high affin-
ity interaction. Figure 1d demonstrates that the majority
of the Nck GST fusion proteins gave single bands after
SDS-PAGE and Commassie-blue staining.
Caskin1 is recruited to the EphB1 tyrosine kinase via Nck
It has been well documented that a number of tyrosine
kinases or their substrates can recruit Nck through its
SH2 domain [6]. One of the tyrosine kinase receptors
present in the nervous system is EphB1 which was
reported to bind to Nck through its phosphorylated Tyr-
594 residue [7]. Therefore, we hypothesized that Nck
could mediate an interaction between EphB1 and
Caskin1. To address this question, first, HA-tagged
EphB1 was transiently expressed in COS7 cells stimu-
lated with ephrin B1 the ligand of the receptor tyrosine
kinase. As Figure 2a demonstrates expression of EphB1
alone in these cells induces activation of the kinase
which is reflected in its tyrosine phosphorylation. Inter-
estingly, addition of the ligand did not further increase
the receptor tyrosine phosphorylation. Other groups also
found that expression of EphB1 or EphA3 in cells leads
to autoactivation of these receptor kinases [11,19].
Next, we tested if Nck could bind to EphB1 in COS7
cells expressing the HA-tagged kinase. It was found
that an antibody against the endogenous Nck could
Figure 1 Nck interacts with Caskin1 through its SH3 domains. (a) Endogenous Caskin1 was immunoprecipitated (IP) from rat brain lysate
with a monoclonal anti-Caskin1 antibody. After SDS-PAGE and transfer to nitrocellulose, samples were analyzed by anti-Nck and anti-Caskin1
antibodies. (b) V5 epitope-tagged Caskin1 and/or GFP-tagged Nck were transiently expressed in COS7 cells, and then cell lysates were
immunoprecipitated with an anti-V5 antibody. Immunoprecipitates were immunoblotted with anti-GFP and anti-V5 antibodies. (c) Full length Nck,
the three SH3 domains together (Nck-SH3-all), and individual SH3 domains (SH3/1, SH3/2 and SH3/3) of Nck were generated as GST fusion
proteins. These fusion proteins were immobilized on glutathione-agarose beads and used for protein precipitations from lysates of COS7 cells
expressing V5-Caskin1. Precipitated proteins were separated on SDS-PAGE and transferred to nitrocellulose, and then samples were
immunoblotted with anti-V5 antibody. (d) Coomassie stained gels with GST fusion proteins used in the previous experiment. These results are
representative of three experiments.
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To prove the existence of the EphB1/Nck/Caskin1
complex, HA-EphB1 and V5-Caskin1 were transiently
coexpressed in COS7 cells, and then cell lysates were
immunoprecipitated with an anti-V5 antibody cova-
lently bound to Sepharose beads. As seen in Figure 3a,
Caskin1 immunoprecipitates both Nck and EphB1.Toprove in a more physiological context that a specific
phosphotyrosine residue in EphB1 may recruit the com-
plex of Nck/Caskin1, we used phosphopeptides immobi-
lized on beads to precipitate proteins, as described earlier
[20,21]. The SH2 domain of Nck1 is known to bind to the
EphB1 autophosphorylation site Y594 and to the PDGF
receptor autophosphorylation site Y751 [7,22]. Therefore,
Figure 2 Expression of EphB1 in COS7 cells results in autoactivation and interaction with Nck. (a) COS7 cells were transiently transfected
with HA-tagged EphB1 and after overnight serum-starvation cells were stimulated with ephrinB1 for 20 minutes or left untreated. Proteins were
immunoprecipitated with anti-EphB1 antibody and probed with anti-phosphotyrosine and anti-HA antibodies. (b) HA-tagged EphB1 was
transiently expressed in COS7 cells. Cell lysates were then subjected to immunoprecipitation with an anti-Nck antibody. Bound proteins were
separated by SDS-PAGE, transferred to nitrocellulose, and probed with anti-phosphotyrosine, anti-HA, and anti-Nck antibodies. These results are
representative of three experiments.
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phosphorylation sites were synthesized (Y594-P and
Y751-P). A control phosphopeptide was also synthesized
based on the autophosphorylation site Y1009 of the PDGF
receptor that cannot bind to Nck1 [7]. Figure 3b demon-
strates that both Nck-specific phosphopeptides, Y594-P
and Y751-P, immobilized on Streptavidin-agarose resin
were capable of precipitating the complex of Nck and
Caskin1 from rat brain lysates, while the control phospho-
peptide was not able to pull-down the proteins. These
experiments strongly suggest that the activated andFigure 3 Caskin1 is recruited to EphB1 tyrosine kinase via Nck. (a) CO
cell lysates were then subjected to immunoprecipitation with anti-V5 antib
nitrocellulose, and probed with anti-HA and anti-Nck antibodies. (b) Biotiny
Y1009-P as negative control) and immobilized on streptavidin-beads as des
rat brain lysates. Precipitated proteins were resolved by SDS-PAGE, transferr
antibodies.autophosphorylated EphB1 receptor may recruit the com-
plex of Nck/Caskin1 in neuronal cells.
EphB1 phosphorylates Caskin1 on tyrosine 296 and 336
It has been well established that receptor tyrosine
kinases bind signaling molecules and often phosphoryl-
ate them [23]. Therefore, we hypothesized that Caskin1
recruited to the activated EphB1 receptor tyrosine
kinases could be subject to tyrosine phosphorylation. To
challenge our hypothesis, Caskin1 and EphB1 were tran-
siently coexpressed in COS7 cells and then tyrosineS7 cells were transiently transfected with HA-EphB1 or/and V5-Caskin1,
ody. Bound proteins were separated by SDS-PAGE, transferred to
lated tyrosine phosphopeptides were synthesized (Y594-P, Y751-P, and
cribed in the Methods. These phosphopeptides were incubated with
ed to nitrocellulose and analyzed by anti-Caskin1 and anti-Nck
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Figure 4a, coexpression of Caskin1 with EphB1 resulted
in a significant tyrosine phosphorylation of the scaffold
protein. We used mass spectrometry to determine the
site(s) of Caskin1 phosphorylation. To this end, Caskin1
was transiently expressed alone or together with EphB1
in COS7 cells and immunoprecipitated with anti-V5
antibody. After SDS-PAGE and staining with Coomassie
blue, protein bands corresponding to unphosphorylated
and EphB1-phosphorylated Caskin1 (Figure 4b) were cut
out from the gel and sent to mass spectrometry analysis.
Two tyrosine residues were identified to be phosphory-
lated in Caskin1: Y296 and Y336 (Additional file 1).
Interestingly, both tyrosine residues are located within
the SH3 domain. To determine the position of the phos-
phorylated tyrosine residues, the 3D structure of the rat
Caskin1 SH3 domain was modeled by using the public
I-TASSER structure prediction server as described inFigure 4 EphB1 phosphorylates Caskin1 on tyrosine 296 and 336 (1).
cells. Cell lysates were then subjected to immunoprecipitation with anti-V5
nitrocellulose, and probed with anti-phosphotyrosine and anti-V5 antibodie
cells as in Figure 4a, however, after immunoprecipitation with anti-V5 antib
the bands sent to mass spectrometry analysis (Caskin1) is indicated. (c) The
public I-TASSER (http://zhanglab.ccmb.med.umich.edu/I-TASSER) structure p
EphB1 are indicated.Methods. As shown in Figure 4c, Tyr296 is localized in
the flexible RT loop linking the first two beta-strands,
while Tyr336 is present in the more compact fourth
beta-strand.
To show definitively that Y296 and Y336 are tyrosine
phosphorylated, phosphospecific antibodies were gener-
ated (anti-PTyr296 and anti-PTyr336). In addition, point
mutations were introduced into the SH3 domain of
Caskin1, changing tyrosine 296 (Y296F) and tyrosine
336 (Y336F), respectively, or both tyrosine 296 and 336
(Y296/336F) to phenylalanines. Caskin1 together with
EphB1 were then transiently coexpressed in COS7 cells
and tyrosine phosphorylation of Caskin1 was probed
with the anti-phosphotyrosine antibody 4G10 or with
the phosphospecific antibodies. Figure 5a demonstrates
that, as shown in Figure 4a, wild type Caskin1 is tyrosine
phoshorylated in the presence of EphB1. However, both
the Caskin1 Y296F and Y336F constructs showed(a) V5-Caskin1 and HA-EphB1 were transiently coexpressed in COS7
antibody. Bound proteins were separated by SDS-PAGE, transferred to
s. (b) V5-Caskin1 and HA-EphB1 were transiently coexpressed in COS7
ody protein samples were stained by Coomassie blue. The position of
3D structure of the rat Caskin1 SH3 domain was modeled using the
rediction server. The positions of the two tyrosines phosphorylated by
Figure 5 EphB1 phosphorylates Caskin1 on tyrosine 296 and 336 (2). (a) Ha-EphB1 and different constructs of V5-Caskin1 were coexpressed
in COS7 cells. Cell lysates were then subjected to immunoprecipitation with anti-V5 antibody. Bound proteins were separated by SDS-PAGE,
transferred to nitrocellulose, and probed with anti-phosphotyrosine and anti-V5 antibodies. (b) HA-EphB1 and different constructs of V5-Caskin1
were coexpressed in COS7 cells. Cell lysates were then subjected to immunoprecipitation with anti-V5 antibody. Bound proteins were separated
by SDS-PAGE, transferred to nitrocellulose, and probed with the phosphospecific anti-PTyr296 and anti-V5 antibodies. (c) HA-EphB1 and different
constructs of V5-Caskin1 were coexpressed in COS7 cells. Proteins were then immunoprecipitated with anti-V5 antibody, then samples were
analyzed by the phosphospecific anti-PTyr336 and anti-V5 antibodies.
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level of phosphorylation was detected when both tyro-
sine residues (Y296/336F) were mutated (Figure 5a).
Next, anti-PTyr296 and anti-PTyr336 antibodies weretested under similar conditions. Tyrosine phosphoryl-
ation of Caskin1 was unambiguously detected with the
anti-PTyr296 antibody which signal was completely
abolished when Y296F or Y296/336F constructs were
Figure 6 Tyrosine phosphorylation leads to structural changes
in the Caskin1 SH3 domain. (a) The SH3 domain of Caskin1 was
expressed, purified, and phosphorylated in vitro by EphB1 as
described in the Methods. The upper panel demonstrates the
phosphorylation of the SH3 domain probed with anti-
phosphotyrosine antibody. The lower panel shows the protein
samples stained with Coomassie blue. (b) Far-UV CD spectra were
measured of the unphosphorylated and the phosphorylated SH3
domains. The CD spectrum of the buffer itself is also indicated.
(c) Near-UV CD spectra were measured of the unphosphorylated
and the phosphorylated SH3 domains. The CD spectrum of the
buffer itself is also indicated. These results are representative of three
experiments. (d) The SH3 domain of Caskin1 was expressed, purified,
and phosphorylated in vitro by EphB1 as described in the Methods.
The upper panel demonstrates the time course of phosphorylation
of the SH3 domain stained with Coomassie-blue. After blotting the
proteins to nitrocellulose membrane, immunoblots were performed
using anti-His-tag and anti-phosphotyrosine antibodies (middle and
lower panels).
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antibody also clearly detected the phosphorylation of
wild type Caskin1. This phosphorylation level was
decreased when the either the Y336F or the Y296/
336F constructs were applied. Taken together, these
results suggest that Caskin1 when recruited to EphB1
tyrosine kinase is phosphorylated on tyrosine residues
296 and 336.
Tyrosine phosphorylation leads to structural changes in
the Caskin1 SH3 domain
Recently, it has emerged that tyrosine phosphorylation
of SH3 domains may negatively regulate protein-protein
associations. It was proposed that the phosphotyrosine
residue(s) and its charge may interfere with binding of
polyproline helices of SH3 domain interacting partners
[24]. However, the potential structural changes caused
by the phosphorylation have not been determined ex-
perimentally so far. Therefore, we expressed and purified
the Caskin1 SH3 domain and phosphorylated it in vitro
by a recombinant active EphB1. Figure 6a demonstrates
that under the applied conditions the SH3 domain is in-
tensively phosphorylated on tyrosine residues. Next, far-
UV CD spectrum was measured which can reveal im-
portant characteristics of the secondary structure of a
protein. As shown in Figure 6b, no major difference was
detected between the spectra of unphosphorylated and
phosphorylated SH3 domains suggesting that phosphor-
ylation of tyrosine residues does not cause significant
changes in the secondary structure. Interestingly, when
near-UV CD spectra were taken noticeable changes were
detected upon tyrosine phosphorylation of the SH3 do-
main. It seems that the chemical environment of these
residues is clearly sensitive to phosphorylation suggest-
ing that tertiary structure of the SH3 domain is likely
altered around the phosphorylated tyrosines. However, it
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structural changes, e.g. dimerization, that could alter the
spectrum. To exclude this possibility, time-course of
Caskin1 phosphorylation was followed at 15°C by using
native gel electrophoresis. Figure 6d demonstrates that
tyrosine phosphorylated Caskin1 SH3 domain migrates
faster than the unphosphorylated protein, possibly due
to the incorporated negative charges. Nevertheless, the
native gel electrophoresis does not show any sign of pro-
tein dimerization or aggregation induced by EphB1-
dependent phosphorylation.
Discussion
Intracellular signaling pathways mediating the biological
effects of ephrins and their receptors have been inten-
sively characterized in the recent years. Although a num-
ber of proteins binding to EphB receptor kinases have
been identified, our knowledge of their function particu-
larly in axonal guidance is still incomplete. Here, we de-
scribe a novel pathway in which the neuron-specific
scaffold protein Caskin1 forms a complex with the
EphB1 receptor via the Nck adaptor protein. Previously,
it has been shown that Caskin1 could bind to several
partners, including Cask, Nck/Dock, LAR receptor pro-
teins tyrosine phosphatase, synaptotagmin, Abi2, and
neurexin [15-17]. However, it is still unclear which re-
ceptor or transmembrane proteins could regulate
Caskin1 function.
Interaction of EphB1 with Nck/Dock has been studied
intensively [7,12,16,17]. Tyrosine 594 within the juxta-
membrane region of EphB1 was shown to be required
for binding the SH2 domain of Nck [7], while its SH3
domains may interact with paxillin, Nck-interacting kin-
ase (NIK), and WASP, participating in the regulation of
actin cytoskeleton [7-9,13]. Association of EphB1 kinase
with Caskin1 through Nck represents the fourth possi-
bility of how EphB1 may signal toward actin cytoskel-
eton (Figure 7). Although the interaction of Nck with
EphB1 is well established, much less is known about the
interaction of Nck SH3 domains with downstream part-
ners. Therefore, we wished to determine which of the
SH3 domains of Nck was required for the interaction. It
seems that none of the individual SH3 domains of Nck
is able to pull-down Caskin1. Instead, all three SH3
domains are necessary for the binding. This finding is
not surprising since many of the binding partners of
Nck require the presence of two or three SH3 domains
for high affinity binding [6,25]. This comes from the fact
that the affinity of the SH3 domains for their ligands
ranges typically from low micromolar to mid-nanomolar
[26-28]. Therefore, SH3 domain containing proteins
apply diverse strategies to increase the strength of the
interaction: they contain multiple SH3 domains, such as
Grb2, Nck or the Tks family of scaffold proteins, or useadditional surfaces for ligand binding on the SH3 do-
main outside the PPII binding groove, such as the highly
variable RT and n-Src loops [26,27].
Complex formation of EphB1 with Caskin1 resulted in
the phosphorylation of tyrosine residues 296 and 336
(Figure 7). Identification of these sites was somewhat
surprising as both tyrosines are localized within the SH3
domain. By modeling the 3D structure of the rat Caskin1
SH3 domain it was found that Tyr296 is localized in the
flexible RT loop linking the first two beta-strands, while
Tyr336 is present in the more compact fourth beta-
strand. Recent evidence suggests that several SH3
domains can be subject of phosphorylation on conserved
tyrosine residues [24]. For example, the C-terminal SH3
domain of Grb2 can be phosphorylated by EGF receptor
or Bcr/Abl on Y209 [29]. This phosphorylation resulted
in reduced binding of proline-rich peptides based on the
structure of the Sos exchange protein [29]. Phosphoryl-
ation of Abi1 adaptor protein by Abl also decreases
binding of Abi1 to Abl kinase [30]. Unfortunately, in the
literature there are no identified binding partners for the
SH3 domain of Caskin1. Therefore, we could not test if
phosphorylation of Caskin1 SH3 domain interferes with
its ligand binding. However, we investigated if the phos-
phorylation could have any effect on the structure of the
protein. Near-UV CD spectra were taken which showed
noticeable changes upon tyrosine phosphorylation of the
SH3 domain. It seems that the chemical environment of
these residues is clearly sensitive to phosphorylation,
suggesting that the tertiary structure of the SH3 domain
is likely altered around the phosphorylated tyrosines.
Nevertheless, it is also possible that pY296 and pY336
may represent binding sites for SH2 domain-containing
signaling molecules thereby positively regulating the
interactions of Caskin1.
Tandem mass spectrometry analysis of mouse postsy-
naptic density and synaptosomal preparations revealed
several serine/threonine phosphorylation sites on the
proline-rich region of Caskin1 [31,32]. Recently, a study
using kinase-selective enrichment for quantitative phos-
phoproteomics identified Y336 in Caskin1 as an in vivo
phosphorylation site [33]. This independent work con-
firms that, at least, Y336 is a physiological phosphoryl-
ation site that might have a regulatory role in the
function of Caskin1. Previous data suggested that cell
surface EphB receptors are likely molecules that trans-
duce extracellular into the dendrite to trigger spine mor-
phogenesis [34,35]. The role of EphB receptors in spine
development is in line with previous reports indicating
that EphB receptors can be found in the post-synaptic
structures of dendrites [36,37]. In addition, another
group has shown that EphB receptor kinases contribute
to dynamic reorganization of the action cytoskeleton
leading to spine morphological features, such as
Figure 7 Proposed model of the EphB1-Caskin1 interaction. Ligand-activated EphB1 recruits the adaptor protein Nck through the
phosphorylated Y594 residue. In turn, Nck forms a complex with Caskin1 via the SH3 domains of Nck. Recruitment of Caskin1 to the vicinity of
the receptor leads to the phosphorylation of the Caskin1 SH3 domain on tyrosine residues 296 and 336. Tyrosine phosphorylated Caskin1 then
likely promotes reorganization of the actin cytoskeleton leading to spine formation. PDZ, (postsynaptic density 95, PSD-85; discs large, Dlg; zonula
occludens-1, ZO-1), SH2, Src-homology domain 2, SH3, Src-homology domain 3, SAM, sterile alpha motif.
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mushroom-like spines [38]. Altogether, these and our
data suggest that EphB receptors recruiting the complex
of Nck and Caskin1 to the plasma membrane may also
contribute to the cytoskeletal organization of dendritic
spines (Figure 7). Nevertheless, further experiments will
be required to better understand the function and regu-
lation of Caskin1 in the nervous system.
Conclusions
In summary, we show here that the scaffold protein
Caskin1 can be recruited to the activated and autopho-
sphorylated EphB1 tyrosine kinase via the Nck protein
as a linker. Complex formation results in tyrosine phos-
phorylation of Caskin1 SH3 domain on tyrosine residues
296 and 336. Although we were not able to identify any
physiological partners of the Caskin1 SH3 domain so far,
we could demonstrate by near-UV CD spectrometry that
phosphorylation on conserved tyrosine residues results
in marked changes in the structure of the SH3 domain.Methods
Antibodies, constructs and reagents
The monoclonal antibody raised against GFP was a kind
gift of Cancer Research UK Hybridoma Development
Unit, London, UK. Polyclonal anti-Caskin1 antibody was
generated against the SAM domains of Caskin1. Mono-
clonal anti-Caskin1 antibody was custom-made by AbD-
Serotec. Monoclonal antibody against Nck (610009) was
from BD Transduction Laboratories. Antibodies against
Nck (polyclonal, 06–288) and the phosphotyrosine
residues (clone 4G10, 05–321) were obtained from Milli-
pore (Billerica, MA). Antibodies against the V5 epitope
(R96025 and A7345) were purchased from Invitrogen
(Carlsbad, CA) and Sigma-Aldrich (St. Louis, MO), re-
spectively. Anti-HA monoclonal antibody (6E2, 2367)
was from Cell Signaling Technologies (Beverly, MA).
Anti-EphB1 polyclonal antibody (Q-20, sc-926) was pur-
chased from Santa Cruz Biotechnology, Inc. Anti-
pTyr296 (DYCNN{pTyr}DLTSLN) and anti-pTyr336
(GNDRVG{pTyr}FPSSLGC) phosphospecific polyclonal
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(Piscataway, NJ).
The full length HA-tagged EphB1 was kindly provided
by Uyen Huynh-Do (University of Bern Medical School,
Bern, Switzerland). The full length rat Caskin1 cDNA
was kindly provided by Thomas Südhof (University of
Texas Southwestern Medical Center, Dallas, TX, USA).
Caskin1 cDNA was amplified by a high-fidelity DNA
polymerase and subcloned into the pcDNA 3.1 / V5-His
TOPO vector (Invitrogen, San Diego, CA, USA). GFP-
Nck and different domain constructs of Nck expressed
as GST fusion proteins were described earlier [25,39].
For pull-down experiments, GST fusion proteins were
purified by binding to glutathione-agarose (Sigma-
Aldrich). Protein purification was monitored on Coo-
massie blue-stained SDS-PAGE gels: the majority of the
GST proteins gave single bands. The DNA fragment en-
coding the rat Caskin1 SH3 domain was amplified by
Pfu Turbo HotStart DNA polymerase (Agilent) from
full-length rat Caskin1 cDNA by PCR and subcloned
into the NdeI/XhoI sites of expression vector pET22b
(New England Biolabs). EphB1-pY594 (PQMKI{pTyr}
IDPFTK), PDGFR-pY751 (DESVD{pTyr}VPMLDK), and
PDGFR-Y1009 (TSSVL{pTyr}TAVQPK) biotinylated
phosphopeptides and the corresponding phosphospecific
antibodies were produced by Invitrogen. V5-Caski-
n1Y296F, V5-Caskin1Y336F, and V5-Caskin1Y296/336F
mutants were generated using the QuickChange Site-
directed Mutagenesis Kit (Stratagene, La Jolla, CA). In
all cases the constructs were verified by DNA sequen-
cing. Stock solutions of ephrin B1-Fc (473-EB-200, R&D
Systems) was prepared according to the manufacturer’s
instructions. Streptavidin-agarose (S1638) and active re-
combinant EphB1 tyrosine kinase (E7032) were pur-
chased from Sigma-Aldrich.
Cell lines, transfection, and stimulation
COS7 cells were purchased from American Type Cul-
ture Collection and maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal
calf serum (Invitrogen), penicillin (100 units/ml), and
streptomycin (50 μg/ml). Cells were transiently trans-
fected with Lipofectamine (Invitrogen) according to the
manufacturer’s instructions. For stimulation, cells were
serum-starved overnight and stimulated with ephrin B1-
Fc at 500 ng/ml for 20 min.
SDS-PAGE and immunoblotting
SDS-PAGE and immunoblotting was performed as
described previously [40]. Briefly, COS7 cells were
washed with ice-cold PBS and lysed in 1 ml of ice-cold
50 mM Hepes buffer, pH 7.4, containing 100 mM NaCl,
1% Triton X-100, 20 mM NaF, 1 mM EGTA, 1 mM
Na3VO4, 1 mM p-nitrophenyl-phosphate, 10 mMbenzamidine, 1 mM phenylmethylsulphonyl fluoride,
25 μg/ml each of leupeptin, soybean trypsin inhibitor
and aprotinin. Lysates were clarified by centrifugation at
15.000 × g for 10 min at 4°C and then incubated for 1 h
at 4°C with 30 μl of anti-V5 agarose affinity gel (A7345,
Sigma-Aldrich), or monoclonal anti-HA agarose (A2095,
Sigma-Aldrich), or 5 μl of monoclonal anti-Caskin1 anti-
body and 25 μl of Protein G Sepharose beads (GE Health-
care), or 5 μl of polyclonal anti-Nck and 25 μl of Protein
A Sepharose beads (Sigma-Aldrich), or with 5 μg of GST
fusion proteins immobilized on glutathione-agarose beads
(GST pull-down experiments). Protein precipitates were
washed three times with ice-cold PBS, pH 7.4, containing
0.4% Triton X-100 and eluted with SDS sample buffer.
Proteins were then separated by SDS-PAGE, transferred
to nitrocellulose membrane and immunoblotted with the
indicated antibodies. Blots were developed by the
enhanced chemiluminescence (ECL, Amersham Pharma-
cia Biotech) system.
In vitro phosphorylation
The kinase reaction mixture (310 μl) included purified
Caskin1 SH3 domain (200 μl, 3.8 mg/ml), a 3-fold kinase
buffer (100 μl - 200 mM Tris buffer, pH 7.5, 20 mM
MgCl2) and 10 μl recombinant, GST-tagged EphB1 re-
ceptor (E7032, Sigma-Aldrich). The phosphorylation was
initiated with 7.5 μl 10 mM ice-cold ATP. The control
reaction mixture did not include ATP. The incubation
was carried out at 30°C for 1 h. For native gel electro-
phoresis, the phosphorylation of Caskin1 was performed
as above, with the exception that the incubation was car-
ried out at 15°C for the indicated times.
Purification of Caskin1 SH3 domain
For structural characterization, the 6x His-tagged SH3
protein was expressed in the E. coli strain BL21 star.
Cells were grown in 500 ml NZYM medium at 37°C,
250 rpm up to an OD600 of 0.5-0.6. Expression of the
protein was induced by 0.5 mM isopropyl thio-β-D-
galactoside (Duchefa) at 20°C for 5 h. Cells were har-
vested by centrifugation for 20 minutes at 4°C and
4000 rpm then lysed in 10 ml binding buffer (20 mM so-
dium phosphate pH 7.4, 500 mM NaCl and 20 mM
imidazole). After sonication for 10 seconds 10 times, the
cell lysate was treated with 1% Triton X-100 for 30 minutes
on ice. The cell debris was removed by centrifugation for
40 minutes at 4°C and 50.000 rpm and the supernatant
was subsequently cleared by using a 0.20 μM filter. The
protein was purified in AKTA Explorer Protein Purification
System (GE Healthcare) supplied with a 1 ml HisTrap HP
column (GE Healthcare). The loading of the cleared lysate
onto the pre-equilibrated column was followed by a 10 col-
umn volume washing step using the binding buffer. The
target protein was eluted with the same buffer containing
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containing the 6xHis tagged Caskin1 SH3 domain were
applied to an AKTA HiPrep 26/10 Desalting column
(GE Healthcare) to remove imidazole and to change the
buffer to the appropriate one. The purity of the protein
was monitored by SDS-PAGE.
Phosphorylation site mapping
Gel bands were cleaned-up with in-gel reduction
(10 mM DTT) and alkylation (50 mM IAA) prior to in-
gel digestion with trypsin. In-gel reduction/alkylation:
10 mM DTT in 100 mM ammonium bicarbonate was
added to gel bands and incubated at 56°C for 60 mins,
the buffer was then discarded. Next, 50 mM IAA in
100 mM ammonium bicarbonate was added to gel bands
and incubated at room temperature in the dark for
30 mins, the buffer was then discarded. Gel bands were
then washed in 50:50 ammonium bicarbonate (20 mM):
acetonitrile, then 100% acetonitrile, (all 15 mins – buffer
s then discarded). Gel bands were dried in speed vac. In-
gel trypsin digestion: stock trypsin (Roche modified se-
quencing grade) was prepared at 1 mg/ml concentration
in 1 mM HCL and stored at −20°C until required. This
stock solution was adjusted to 12.5 ug/ml in 20 mM am-
monium bicarbonate and added to dry gel bands – just
enough to rehydrate gel bands and cover. Digests were
then incubated overnight at 30°C on shaking platform.
The next day an equal volume of acetonitrile was added
and incubated for 20 mins.
Phosphopeptide enrichment Strong cation exchange
(SCX) fractionation of tryptic peptides was performed on
a 3.0-mm× 20-cm column (Poly LC, Columbia, MD) con-
taining 5-μm polysulfoethyl aspartamide beads with a
200-Å pore size. The first 15 SCX fractions were freeze
dried and subjected to titanium dioxide (TiO2) chroma-
tography as follows. Each SCX fraction was redissolved in
50 μl of 200 mg/ml 2,5-dihydroxybenzoic acid dissolved in
80% acetonitrile, 2% trifluoroacetic and incubated for
5 min with ∼ 2 mg of TiO2 beads that had been prewashed
in the same solution. The beads were then transferred into
a ZipTipC18(Millipore) and washed twice with 45 μl of
80% acetonitrile, 2% trifluoroacetic. Bound peptides were
eluted with 30 μl of 0.6% ammonia solution, pH 10.5, and
the eluted phosphopeptides that absorbed to the under-
lying C18 material of the ZipTip were eluted with 10 μl of
30% acetonitrile followed by 10 μl of 50% acetonitrile,
0.05% trifluoroacetic acid. The combined eluates were
dried, reconstituted in 20 μl of 5% formic acid, vortexed
vigorously, and diluted to a final concentration of 1% for-
mic acid with water for LC-MS/MS analysis.
Liquid chromatography-mass spectrometry Liquid
chromatography was performed on a fully automatedUltiMate Nano LC System (Dionex) fitted with a 1 × 5-
mm PepMap C18 trap column and a 75-μm× 15-cm re-
verse phase PepMap C18 analytical nanocolumn (LC
Packings, Dionex). Samples were loaded in 0.1% formic
acid (buffer A) and separated using a binary gradient con-
sisting of buffer A and buffer B (90% acetonitrile, 0.08%
formic acid). Peptides were eluted with a linear gradient
from 5 to 40% buffer B over 130 min. The HPLC system
was either coupled to a hybrid quadrupole time-of-flight
mass spectrometer (QSTAR XL, Applied Biosystems) or
an LTQ-Orbitrap mass spectrometer (Thermo Electron),
both equipped with a nanospray ionization source.
Software Chromeleon on the dionex ultimate 3000 and
analyst 1.4.1 On the 4000 QTRAP
Data analysis The MSMS data is extracted into a peak
list file (it is usually called *.tmp) using a script in Ana-
lyst 1.4.1. This peak list file is used by Mascot for data-
base searching.
CD spectroscopy
Far UV circular dichroism (CD) spectra were measured
with a Jasco J-720 spectropolarimeter using a quartz cu-
vette with a 1 mm path length in a continuous mode
with a bandwidth of 1 nm, response time of 8 s and scan
speed of 20 nm˙min-1. All measurements were per-
formed at 25°C and each spectrum is an average of four
scans. Spectra were recorded in 10 mM Na2HPO4,
50 mM NaCl (pH = 7.2) with protein concentrations of
50 μM. Background spectra without protein were col-
lected and subtracted from spectra taken in the presence
of proteins. Near UV spectra were recorded under the
same conditions except that a 1 cm path length and
110 μM protein concentration was used.
Modeling the 3D structure of the rat Caskin1 SH3 domain
The 3D structure of the rat Caskin1 SH3 domain was
modeled using the public I-TASSER (http://zhanglab.
ccmb.med.umich.edu/I-TASSER) structure prediction
server. During the modeling the following template
structures were used: NMR solution structure of the
human Caskin2 SH3 domain, 2ke9; actin-binding pro-
tein SH3 domain from S. cerevisiae, 2k3b; SH3 domain
of the human Grb2-like protein 3, 2ew3. The sequence












Native gel electrophoresis has been used to determine if
the in vitro phosphorylation causes dimerization or ag-
gregation of the SH3 domain. Protein samples were run
on a 12,5% non-denaturing polyacrylamide gel. The gel
was run at 50 V for 2 hrs in a 4°C cold cabinet.
Additional file
Additional file 1: Phosphomapping Results of Caskin1 and
P-Caskin1.
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